Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) has implemented its long-term incentive plan to its senior executives, including the CEO and CFO, along with share options for all employees. These awards are designed to encourage company growth and align staff interests with shareholders. The plan was first announced last November and later approved by 99.7% of shareholders at the company's AGM. For more information click here.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com